Update on colchicine, 2017
Anastasia Slobodnick
1, 2
,
Binita Shah
2, 3
,
Svetlana Krasnokutsky
1, 2
,
Michael H. Pillinger
1, 2
2
Rheumatology and Cardiology Sections, VA New York Harbor Health Care System, U.S. Department of Veterans Affairs
|
Publication type: Journal Article
Publication date: 2017-12-19
scimago Q1
wos Q1
SJR: 1.721
CiteScore: 9.9
Impact factor: 4.4
ISSN: 14620324, 14620332, 14602172
PubMed ID:
29272515
Pharmacology (medical)
Rheumatology
Abstract
Colchicine is an ancient medication that is currently approved for the treatment of gout and FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies indicate that it may be beneficial in a variety of other conditions. This paper reviews the evidence for the well-established use of colchicine in gout, as well as several other rheumatic diseases. In addition, we highlight the potential benefit of colchicine in cardiac disease, including coronary artery disease in patients both with and without gout.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
International Journal of Molecular Sciences
5 publications, 2.42%
|
|
|
Molecules
4 publications, 1.93%
|
|
|
European Journal of Internal Medicine
4 publications, 1.93%
|
|
|
Journal of Clinical Medicine
3 publications, 1.45%
|
|
|
Frontiers in Cardiovascular Medicine
3 publications, 1.45%
|
|
|
Zeitschrift fur Rheumatologie
3 publications, 1.45%
|
|
|
Rheumatology International
3 publications, 1.45%
|
|
|
European Heart Journal
3 publications, 1.45%
|
|
|
Rheumatology
3 publications, 1.45%
|
|
|
BMJ Case Reports
3 publications, 1.45%
|
|
|
Journal of Medicinal Chemistry
2 publications, 0.97%
|
|
|
Pharmaceuticals
2 publications, 0.97%
|
|
|
Medicina
2 publications, 0.97%
|
|
|
Frontiers in Immunology
2 publications, 0.97%
|
|
|
Pharmaceutics
2 publications, 0.97%
|
|
|
Cardiovascular Drugs and Therapy
2 publications, 0.97%
|
|
|
Scientific Reports
2 publications, 0.97%
|
|
|
Drugs
2 publications, 0.97%
|
|
|
Journal of Drug Delivery Science and Technology
2 publications, 0.97%
|
|
|
Seminars in Arthritis and Rheumatism
2 publications, 0.97%
|
|
|
FMC Formacion Medica Continuada en Atencion Primaria
2 publications, 0.97%
|
|
|
Toxicology
2 publications, 0.97%
|
|
|
Journal of the American College of Cardiology
2 publications, 0.97%
|
|
|
Meditsinskiy sovet = Medical Council
2 publications, 0.97%
|
|
|
Cochrane Database of Systematic Reviews
2 publications, 0.97%
|
|
|
Cardiology in Review
2 publications, 0.97%
|
|
|
Critical Care
1 publication, 0.48%
|
|
|
Circulation
1 publication, 0.48%
|
|
|
Current Rheumatology Reviews
1 publication, 0.48%
|
|
|
1
2
3
4
5
|
Publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
52 publications, 25.12%
|
|
|
Springer Nature
42 publications, 20.29%
|
|
|
MDPI
23 publications, 11.11%
|
|
|
Wiley
13 publications, 6.28%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
10 publications, 4.83%
|
|
|
Taylor & Francis
9 publications, 4.35%
|
|
|
Frontiers Media S.A.
8 publications, 3.86%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 2.9%
|
|
|
SAGE
6 publications, 2.9%
|
|
|
Oxford University Press
6 publications, 2.9%
|
|
|
American Chemical Society (ACS)
5 publications, 2.42%
|
|
|
Georg Thieme Verlag KG
3 publications, 1.45%
|
|
|
BMJ
3 publications, 1.45%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.97%
|
|
|
Hindawi Limited
2 publications, 0.97%
|
|
|
Remedium, Ltd.
2 publications, 0.97%
|
|
|
S. Karger AG
2 publications, 0.97%
|
|
|
Massachusetts Medical Society
1 publication, 0.48%
|
|
|
Spandidos Publications
1 publication, 0.48%
|
|
|
The Egyptian Society for Joint Diseases and Arthritis
1 publication, 0.48%
|
|
|
PeerJ
1 publication, 0.48%
|
|
|
Radcliffe Media Media Ltd
1 publication, 0.48%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.48%
|
|
|
The Journal of Rheumatology
1 publication, 0.48%
|
|
|
OAE Publishing Inc.
1 publication, 0.48%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.48%
|
|
|
American College of Physicians
1 publication, 0.48%
|
|
|
International Heart Journal (Japanese Heart Journal)
1 publication, 0.48%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.48%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
207
Total citations:
207
Citations from 2024:
47
(22.7%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1093/rheumatology/kex453
UR - https://doi.org/10.1093/rheumatology/kex453
TI - Update on colchicine, 2017
T2 - Rheumatology
AU - Slobodnick, Anastasia
AU - Shah, Binita
AU - Krasnokutsky, Svetlana
AU - Pillinger, Michael H.
PY - 2017
DA - 2017/12/19
PB - Oxford University Press
SP - i4-i11
IS - suppl_1
VL - 57
PMID - 29272515
SN - 1462-0324
SN - 1462-0332
SN - 1460-2172
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Slobodnick,
author = {Anastasia Slobodnick and Binita Shah and Svetlana Krasnokutsky and Michael H. Pillinger},
title = {Update on colchicine, 2017},
journal = {Rheumatology},
year = {2017},
volume = {57},
publisher = {Oxford University Press},
month = {dec},
url = {https://doi.org/10.1093/rheumatology/kex453},
number = {suppl_1},
pages = {i4--i11},
doi = {10.1093/rheumatology/kex453}
}
Cite this
MLA
Copy
Slobodnick, Anastasia, et al. “Update on colchicine, 2017.” Rheumatology, vol. 57, no. suppl_1, Dec. 2017, pp. i4-i11. https://doi.org/10.1093/rheumatology/kex453.